Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

JAN 02, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Raises PT to $13 on Synergy Pharmaceuticals on Positive Data

Cantor Fitzgerald reiterated its Buy rating on Synergy Pharmaceuticals (NASDAQ: SGYP) and increased its price target from $7 to $13. Cantor Fitzgerald commented, "Positive data announcement is a key catalyst: Synergy announced positive top-line results from its Phase IIb/III chronic constipation (CC) trial of plecanatide.

Tags: UPDATE: Cantor Fitzgerald Raises PT to $13 on Synergy Pharmaceuticals on Positive Data,  Cantor Fitzgerald Latest News